These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30995664)

  • 1. Inhibition of Heat Shock Factor 1 Enhances Repressive Molecular Mechanisms on the POMC Promoter.
    Ciato D; Li R; Monteserin Garcia JL; Papst L; D'Annunzio S; Hristov M; Tichomirowa MA; Belaya Z; Rozhinskaya L; Buchfelder M; Theodoropoulou M; Paez-Pereda M; Stalla GK
    Neuroendocrinology; 2019; 109(4):362-373. PubMed ID: 30995664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
    Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the EGFR Pathway by HSP90 Is Involved in the Pathogenesis of Cushing's Disease.
    Shen Y; Ji C; Jian X; Zhou J; Zhang Q; Qiao N; Zhang Y; Shou X; Zhou X; Ma Z
    Front Endocrinol (Lausanne); 2020; 11():601984. PubMed ID: 33537004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the ERK pathway for the treatment of Cushing's disease.
    Zhang D; Bergsneider M; Wang MB; Heaney AP
    Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter.
    Yoon YJ; Kim JA; Shin KD; Shin DS; Han YM; Lee YJ; Lee JS; Kwon BM; Han DC
    J Biol Chem; 2011 Jan; 286(3):1737-47. PubMed ID: 21078672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
    Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
    Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
    Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
    J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells.
    Nakada Y; Kageyama K; Sugiyama A; Desaki R; Takayasu S; Niioka K; Murasawa S; Ishigame N; Asari Y; Iwasaki Y; Daimon M
    Endocr J; 2015; 62(12):1083-90. PubMed ID: 26497760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease.
    Lu J; Chatain GP; Bugarini A; Wang X; Maric D; Walbridge S; Zhuang Z; Chittiboina P
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2825-2835. PubMed ID: 28505327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing's disease and subclinical Cushing's disease.
    Tabuchi Y; Kitamura T; Fukuhara A; Mukai K; Onodera T; Miyata Y; Hamasaki T; Oshino S; Saitoh Y; Morii E; Otsuki M; Shimomura I
    Endocr J; 2016 Jun; 63(6):545-54. PubMed ID: 27025408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
    Sekizaki T; Kameda H; Nakamura A; Kuwabara S; Nomoto H; Cho KY; Ishi Y; Motegi H; Miyoshi H; Atsumi T
    Pituitary; 2023 Oct; 26(5):597-610. PubMed ID: 37642928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of histone deacetylase 1/2 in adrenocorticotropic hormone synthesis and proliferation of corticotroph tumor AtT-20 cells.
    Hagiwara R; Kageyama K; Niioka K; Takayasu S; Tasso M; Daimon M
    Peptides; 2021 Feb; 136():170441. PubMed ID: 33181265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
    Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription Factor ASCL1 Acts as a Novel Potential Therapeutic Target for the Treatment of the Cushing's Disease.
    Chen Z; Jia Q; Zhao Z; Zhang Q; Chen Y; Qiao N; Ye Z; Ji C; Zhang Y; He W; Shi C; Cai Y; Yao B; Han R; Wang Y; Shou X; Shen M; Cao X; Zhou X; Cheng H; Zhu J; Hu Y; Zhang Z; Ye H; Li Y; Li S; Wang Y; Ma Z; Ni T; Zhao Y
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2296-2306. PubMed ID: 35521682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
    Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
    Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F1-mediated human POMC expression in ectopic Cushing's syndrome.
    Araki T; Liu NA; Tone Y; Cuevas-Ramos D; Heltsley R; Tone M; Melmed S
    Endocr Relat Cancer; 2016 Nov; 23(11):857-870. PubMed ID: 27935805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin, an HSP90 Inhibitor, on Human ACTH-Secreting Adenomas.
    Pecori Giraldi F; Cassarino MF; Sesta A; Lasio G; Losa M
    Neuroendocrinology; 2023; 113(6):606-614. PubMed ID: 36791678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why don't corticotroph tumors always produce Cushing's disease?
    García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
    Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.